Prospects of apoptotic cell-based therapies for transplantation and inflammatory diseases

Immunotherapy

Volumn 5, Issue 10, 2013, Pages 1055-1073

  Saas, Philippe ^a,b,c,d   Kaminski, Sandra ^a,b,c,d   Perruche, Sylvain ^a,b,c,d  

^a France   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d LabEX LipSTIC   (France)

Author keywords

apoptotic cells; arthritis; cell therapy; dendritic cells; immunotherapy; inflammation; macrophages; tolerance; transplantation; Tregs

Indexed keywords

ARGINASE; ARGINASE 1; ARGINASE 2; CHEMOKINE RECEPTOR CCR7; COLONY STIMULATING FACTOR 1; COMPLEMENT COMPONENT C1Q; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PROSTAGLANDIN E2; RETINOID; SECONDARY LYMPHOID TISSUE CHEMOKINE; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACUTE GRAFT REJECTION; ACUTE GRAFT VERSUS HOST DISEASE; ACUTE HEART INFARCTION; ALLERGIC ENCEPHALOMYELITIS; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN PRESENTATION; APOPTOSIS; APOPTOTIC CELL BASED THERAPY; ARTHRITIS; CELL DIFFERENTIATION; CELL THERAPY; CELL TRANSPLANTATION; CHRONIC GRAFT REJECTION; CHRONIC GRAFT VERSUS HOST DISEASE; CONTACT ALLERGY; CYTAPHERESIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVITY; HEPATITIS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; KUPFFER CELL; MACROPHAGE; MICROENVIRONMENT; MICROGLIA; NEUTROPHIL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; REVIEW; SEPSIS; T LYMPHOCYTE; ULTRAVIOLET B RADIATION;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CELL- AND TISSUE-BASED THERAPY; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSION; MODELS, ANIMAL; TRANSPLANTATION;

EID: 84885209262     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.13.103     Document Type: Review

References (155)

1. De Carvalho Bittencourt M, Tiberghien P, Saas P. Transplantation of anergic histoincompatible bone marrow cells. N. Engl. J. Med. 341(14), 1081-1082 (1999).
2. Bittencourt MC, Perruche S, Contassot E et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 98(1), 224-230 (2001). n The first manuscript reporting the beneficial use of apoptotic cell infusion in an experimental model of allogeneic hematopoietic cell transplantation.
3. Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am. J. Pathol. 171(1), 2-8 (2007).
4. Newman SL, Henson JE, Henson PM. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J. Exp. Med. 156(2), 430-442 (1982).
5. Ariel A, Serhan CN. New lives given by Cell Death: Macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front. Immunol. 3, 4 (2012).
6. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: Clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2(12), 965-975 (2002).
7. Gregory CD, Pound JD. Cell Death in the neighbourhood: Direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J. Pathol. 223(2), 177-194 (2011).
8. Ochsenbein AF, Klenerman P, Karrer U et al. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc. Natl Acad. Sci. USA 96(5), 2233-2238 (1999).
9. Kurosaka K, Takahashi M, Watanabe N, Kobayashi Y. Silent cleanup of very early apoptotic cells by macrophages. J. Immunol. 171(9), 4672-4679 (2003).
10. Morimoto K, Amano H, Sonoda F et al. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am. J. Respir. Cell. Mol. Biol. 24(5), 608-615 (2001).
11. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-b, PGE2, and PAF. J. Clin. Invest. 101(4), 890-898 (1998).
12. Miyake Y, Asano K, Kaise H, Uemura M, Nakayama M, Tanaka M. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J. Clin. Invest. 117(8), 2268-2278 (2007).
13. Wermeling F, Chen Y, Pikkarainen T et al. Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus. J. Exp. Med. 204(10), 2259-2265 (2007).
14. Kleinclauss F, Perruche S, Masson E et al. Intravenous apoptotic spleen cell infusion induces a TGF-b-dependent regulatory T-cell expansion. Cell Death Differ. 13(1), 41-52 (2006).
15. Seitz HM, Camenisch TD, Lemke G, Earp HS, Matsushima GK. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. J. Immunol. 178(9), 5635-5642 (2007).
16. Zizzo G, Hilliard BA, Monestier M, Cohen PL. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J. Immunol. 189(7), 3508-3520 (2012).
17. Chang GH, Barbaro NM, Pieper RO. Phosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microglia, astrocytes, and glioma cells. Neuro Oncol. 2(3), 174-183 (2000).
18. Chan A, Seguin R, Magnus T et al. Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: Termination of CNS autoimmune inflammation and modulation by interferon-b. Glia 43(3), 231-242 (2003).
19. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201(4), 647-657 (2005).
20. Hughes MM, Field RH, Perry VH, Murray CL, Cunningham C. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation. Glia 58(16), 2017-2030 (2010).
21. Huang FP, Platt N, Wykes M et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191(3), 435-444 (2000).
22. Iyoda T, Shimoyama S, Liu K et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195(10), 1289-1302 (2002).
23. Morelli AE, Larregina AT, Shufesky WJ et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: Dependence on complement receptors and effect on cytokine production. Blood 101(2), 611-620 (2003).
24. Ravichandran KS. Beginnings of a good apoptotic meal: The find-me and eat-me signaling pathways. Immunity 35(4), 445-455 (2011).
25. Chung EY, Liu J, Homma Y et al. Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity 27(6), 952-964 (2007).
26. Zhang Y, Kim HJ, Yamamoto S, Kang X, Ma X. Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells. J. Interferon Cytokine Res. 30(3), 113-122 (2010).
27. De Simone R, Ajmone-Cat MA, Tirassa P, Minghetti L. Apoptotic PC12 cells exposing phosphatidylserine promote the production of anti-inflammatory and neuroprotective molecules by microglial cells. J. Neuropathol. Exp. Neurol. 62(2), 208-216 (2003).
28. Municio C, Hugo E, Alvarez Y et al. Apoptotic cells enhance IL-10 and reduce IL-23 production in human dendritic cells treated with zymosan. Mol. Immunol. 49(1-2), 97-106 (2011).
29. Segura E, Touzot M, Bohineust A et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38(2), 336-348 (2013).
30. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 390(6658), 350-351 (1997).
31. Perruche S, Zhang P, Liu Y, Saas P, Bluestone JA, Chen W. CD3-specific antibody-induced immune tolerance involves transforming growth factor-b from phagocytes digesting apoptotic T cells. Nat. Med. 14(5), 528-535 (2008).
32. Garabuczi E, Kiss B, Felszeghy S, Tsay GJ, Fesus L, Szondy Z. Retinoids produced by macrophages engulfing apoptotic cells contribute to the appearance of transglutaminase 2 in apoptotic thymocytes. Amino Acids 44(1), 235-244 (2013).
33. Williams CA, Harry RA, McLeod JD. Apoptotic cells induce dendritic cell-mediated suppression via interferon-g-induced IDO. Immunology 124(1), 89-101 (2008).
34. Ravishankar B, Liu H, Shinde R et al. Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase. Proc. Natl Acad. Sci. USA 109(10), 3909-3914 (2012).
35. Dalli J, Serhan CN. Specific lipid mediator signatures of human phagocytes: Microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 120(15), e60-e72 (2012).
36. Notley CA, Brown MA, Wright GP, Ehrenstein MR. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J. Immunol. 186(8), 4967-4972 (2011).
37. Shibata T, Nagata K, Kobayashi Y. Cutting edge: A critical role of nitric oxide in preventing inflammation upon apoptotic cell clearance. J. Immunol. 179(6), 3407-3411 (2007).
38. Shibata T, Nagata K, Kobayashi Y. A suppressive role of nitric oxide in MIP-2 production by macrophages upon coculturing with apoptotic cells. J. Leukoc. Biol. 80(4), 744-752 (2006).
39. Kim S, Elkon KB, Ma X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21(5), 643-653 (2004).
40. Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22(3), 285-294 (2005).
41. Stuart LM, Lucas M, Simpson C, Lamb J, Savill J, Lacy-Hulbert A. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J. Immunol. 168(4), 1627-1635 (2002).
42. Ariel A, Fredman G, Sun YP et al. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat. Immunol. 7(11), 1209-1216 (2006).
43. Chen W, Frank ME, Jin W, Wahl SM. TGF-b released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14(6), 715-725 (2001).
44. Gao Y, Herndon JM, Zhang H, Griffith TS, Ferguson TA. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188(5), 887-896 (1998).
45. Verbovetski I, Bychkov H, Trahtemberg U et al. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J. Exp. Med. 196(12), 1553-1561 (2002).
46. Ip WK, Lau YL. Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. J. Immunol. 173(1), 189-196 (2004).
47. Abbas AK, Benoist C, Bluestone JA. Regulatory T cells: Recommendations to simplify the nomenclature. Nat. Immunol. 14, 307-308 (2013).
48. Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ. Transfusion of apoptotic b-cells induces immune tolerance to b-cell antigens and prevents Type 1 diabetes in NOD mice. Diabetes 56(8), 2116-2123 (2007).
49. Torchinsky MB, Garaude J, Martin AP, Blander JM. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458(7234), 78-82 (2009).
50. Bellingan GJ, Caldwell H, Howie SE, Dransfield I, Haslett C. In vivo fate of the inflammatory macrophage during the resolution of inflammation: Inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J. Immunol. 157(6), 2577-2585 (1996).
51. Schif-Zuck S, Gross N, Assi S, Rostoker R, Serhan CN, Ariel A. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: Modulation by resolvins and glucocorticoids. Eur. J. Immunol. 41(2), 366-379 (2011).
52. De lamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells De termines antigen fate. Science 307(5715), 1630-1634 (2005).
53. Segura E, Durand M, Amigorena S. Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J. Exp. Med. 210(5), 1035-1047 (2013).
54. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 496(7446), 445-455 (2013).
55. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563-604 (2013).
56. Xu W, Roos A, Schlagwein N, Woltman AM, Daha MR, van Kooten C. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107(12), 4930-4937 (2006).
57. Uderhardt S, Herrmann M, Oskolkova OV et al. 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity 36(5), 834-846 (2012).
58. Ravishankar B, Chandler, P, McGaha T. Early events in immunologic tolerance to apoptotic cells are De pendent on marginal zone macrophage CCL22 production. J. Immunol. 190(Suppl.), Abstract 4081 (2013).
59. Soroosh P, Doherty TA, Duan W et al. Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J. Exp. Med. 210(4), 775-788 (2013).
60. Zigmond E, Jung S. Intestinal macrophages: Well educated exceptions from the rule. Trends Immunol. 34(4), 162-168 (2013).
61. Segura E, Valladeau-Guilemond J, Donnadieu MH, Sastre-Garau X, Soumelis V, Amigorena S. Characterization of resident and migratory dendritic cells in human lymph nodes. J. Exp. Med. 209(4), 653-660 (2012).
62. Idoyaga J, Fiorese C, Zbytnuik L et al. Specialized role of migratory dendritic cells in peripheral tolerance induction. J. Clin. Invest. 123(2), 844-854 (2013).
63. Qiu CH, Miyake Y, Kaise H, Kitamura H, Ohara O, Tanaka M. Novel subset of CD8{a}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J. Immunol. 182(7), 4127-4136 (2009).
64. Vitali C, Mingozzi F, Broggi A et al. Migratory, and not lymphoid-resident, dendritic cells maintain peripheral self-tolerance and prevent autoimmunity via induction of iTreg cells. Blood 120(6), 1237-1245 (2012).
65. Guilliams M, Crozat K, Henri S et al. Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells. Blood 115(10), 1958-1968 (2010).
66. Mucida D, Pino-Lagos K, Kim G et al. Retinoic acid can directly promote TGF-b-mediated Foxp3(+) Treg cell conversion of naive T cells. Immunity 30(4), 471-472; author reply 472-473 (2009).
67. Yamazaki S, Dudziak D, Heidkamp GF et al. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 181(10), 6923-6933 (2008).
68. Desch AN, Randolph GJ, Murphy K et al. CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J. Exp. Med. 208(9), 1789-1797 (2011).
69. Li J, Park J, Foss D, Goldschneider I. Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus. J. Exp. Med. 206(3), 607-622 (2009).
70. Hadeiba H, Lahl K, Edalati A et al. Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity 36(3), 438-450 (2012).
71. Parnaik R, Raff MC, Scholes J. Differences between the clearance of apoptotic cells by professional and non-professional phagocytes. Curr. Biol. 10(14), 857-860 (2000).
72. Wagner BJ, Lindau D, Ripper D et al. Phagocytosis of dying tumor cells by human peritoneal mesothelial cells. J. Cell Sci. 124(Pt 10), 1644-1654 (2011).
73. Wood W, Turmaine M, Weber R et al. Mesenchymal cells engulf and clear apoptotic footplate cells in macrophageless PU.1 null mouse embryos. development 127(24), 5245-5252 (2000).
74. Dini L, Lentini A, Diez GD et al. Phagocytosis of apoptotic bodies by liver endothelial cells. J. Cell Sci. 108(Pt 3), 967-973 (1995).
75. Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu. Rev. Immunol. 28, 321-342 (2010).
76. Kirsch T, Woywodt A, Beese M et al. Engulfment of apoptotic cells by microvascular endothelial cells induces proinflammatory responses. Blood 109(7), 2854-2862 (2007).
77. Tso GH, Law HK, Tu W, Chan GC, Lau YL. Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cells. Stem Cells 28(5), 939-954 (2010).
78. Coles HS, Burne JF, Raff MC. Large-scale normal Cell Death in the developing rat kidney and its reduction by epidermal growth factor. development 118(3), 777-784 (1993).
79. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118(5), 1657-1668 (2008).
80. Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V. Plasmacytoid dendritic cells: Recent progress and open questions. Annu. Rev. Immunol. 29, 163-183 (2011).
81. Ochando JC, Homma C, Yang Y et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7(6), 652-662 (2006).
82. Hoeffel G, Ripoche AC, Matheoud D et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27(3), 481-492 (2007).
83. Bastos-Amador P, Perez-Cabezas B, Izquierdo-Useros N et al. Capture of cell-derived microvesicles (exosomes and apoptotic bodies) by human plasmacytoid dendritic cells. J. Leukoc. Biol. 91(5), 751-758 (2012).
84. Schiller M, Parcina M, Heyder P et al. Induction of type I IFN is a physiological immune reaction to apoptotic cell-derived membrane microparticles. J. Immunol. 189(4), 1747-1756 (2012).
85. Bonnefoy F, Perruche S, Couturier M et al. Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J. Immunol. 186(10), 5696-5705 (2011).
86. Wang Z, Shufesky WJ, Montecalvo A, Divito SJ, Larregina AT, Morelli AE. In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS ONE 4(3), e4940 (2009).
87. Angelot F, Seilles E, Biichle S et al. Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: Potential implications in inflammatory diseases. Haematologica 94(11), 1502-1512 (2009).
88. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 417(6885), 182-187 (2002).
89. Ishimoto Y, Ohashi K, Mizuno K, Nakano T. Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J. Biochem. 127(3), 411-417 (2000).
90. Galvan MD, Greenlee-Wacker MC, Bohlson SS. C1q and phagocytosis: The perfect complement to a good meal. J. Leukoc. Biol. 92(3), 489-497 (2012).
91. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: Signals for a good meal. Nat. Rev. Immunol. 7(12), 964-974 (2007).
92. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-b1 secretion and the resolution of inflammation. J. Clin. Invest. 109(1), 41-50 (2002).
93. Asano K, Miwa M, Miwa K et al. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J. Exp. Med. 200(4), 459-467 (2004).
94. Bondanza A, Zimmermann VS, Rovere-Querini P et al. Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J. Exp. Med. 200(9), 1157-1165 (2004).
95. Cohen PL, Caricchio R, Abraham V et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196(1), 135-140 (2002).
96. Hanayama R, Nagata S. Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8. Proc. Natl Acad. Sci. USA 102(46), 16886-16891 (2005).
97. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188(12), 2313-2320 (1998).
98. Ogden CA, De Cathelineau A, Hoffmann PR et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194(6), 781-795 (2001).
99. Paidassi H, Tacnet-Delorme P, Garlatti V et al. C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. J. Immunol. 180(4), 2329-2338 (2008).
100. Galvan MD, Foreman DB, Zeng E, Tan JC, Bohlson SS. Complement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells. J. Immunol. 188(8), 3716-3723 (2012).
101. Benoit ME, Clarke EV, Morgado P, Fraser DA, Tenner AJ. Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. J. Immunol. 188(11), 5682-5693 (2012).
102. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26(4), 239-257 (1972).
103. Galluzzi L, Vitale I, Abrams JM et al. Molecular definitions of Cell Death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19(1), 107-120 (2012).
104. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell Death. Nat. Rev. Immunol. 9(5), 353-363 (2009).
105. Griffith TS, Ferguson TA. Cell Death in the maintenance and abrogation of tolerance: The five Ws of dying cells. Immunity 35(4), 456-466 (2011).
106. Getts DR, Turley DM, Smith CE et al. Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. J. Immunol. 187(5), 2405-2417 (2011).
107. Gray M, Miles K, Salter D, Gray D, Savill J. Apoptotic cells protect mice from autoimmune inf lammation by the induction of regulatory B cells. Proc. Natl Acad. Sci. USA 104(35), 14080-14085 (2007).
108. Perruche S, Saas P, Chen W. Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: A potential cell-based therapy? Arthritis Res. Ther. 11(4), R104 (2009).
109. Zhang M, Xu S, Han Y, Cao X. Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-b. Hepatology 53(1), 306-316 (2011).
110. Griffith TS, Kazama H, VanOosten RL et al. Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. J. Immunol. 178(5), 2679-2687 (2007).
111. Maeda A, Schwarz A, Bullinger A, Morita A, Peritt D, Schwarz T. Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: Generation of IL-10 and induction of regulatory T cells. J. Immunol. 181(9), 5956-5962 (2008).
112. Maeda A, Schwarz A, Kernebeck K et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J. Immunol. 174(10), 5968-5976 (2005).
113. Mougel F, Bonnefoy F, Kury-Paulin S et al. Intravenous infusion of donor apoptotic leukocytes before transplantation delays allogeneic islet graft rejection through regulatory T cells. Diabetes Metab. 38(6), 531-537 (2012).
114. Sun E, Gao Y, Chen J et al. Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient. Cell Death Differ. 11(12), 1258-1264 (2004).
115. Wang Z, Larregina AT, Shufesky WJ et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell De letion and regulatory T cells. Am. J. Transplant. 6(6), 1297-1311 (2006).
116. Bonnefoy F, Masson E, Perruche S et al. Sirolimus enhances the effect of apoptotic cell infusion on hematopoietic engraftment and tolerance induction. Leukemia 22(7), 1430-1434 (2008).
117. Perruche S, Kleinclauss F, Bittencourt Mde C, Paris D, Tiberghien P, Saas P. Intravenous infusion of apoptotic cells simultaneously with allogeneic hematopoietic grafts alters anti-donor humoral immune responses. Am. J. Transplant. 4(8), 1361-1365 (2004).
118. Ankersmit HJ, Hoetzenecker K, Dietl W et al. Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur. J. Clin. Invest. 39(6), 445-456 (2009).
119. Lichtenauer M, Mildner M, Baumgartner A et al. Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res. Cardiol. 106(4), 645-655 (2011).
120. Saas P, Gaugler B, Perruche S. Intravenous apoptotic cell infusion as a cell-based therapy toward improving hematopoietic cell transplantation outcome. Ann. N.Y. Acad. Sci. 1209, 118-126 (2010).
121. Ren Y, Xie Y, Jiang G et al. Apoptotic cells protect mice against lipopolysaccharide-induced shock. J. Immunol. 180(7), 4978-4985 (2008).
122. Hotchkiss RS, Chang KC, Grayson MH et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc. Natl Acad. Sci. USA 100(11), 6724-6729 (2003).
123. Perruche S, Kleinclauss F, Angonin R et al. A single intravenous infusion of apoptotic cells, an alternative cell-based therapy approach facilitating hematopoietic cell engraftment, does not induce autoimmunity. J. Hematother. Stem Cell Res. 12(4), 451-459 (2003).
124. Mebius RE, Kraal G. Structure and function of the spleen. Nat. Rev. Immunol. 5(8), 606-616 (2005).
125. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 373(9674), 1550-1561 (2009).
126. Mevorach D, Shapira MY, Zuckerman T, Zazoon J, Grau A, Rowe JM. Early apoptotic cells cellular treatment in allogeneic haematopoietic cell transplantation. Bone Marrow Transplant. 46(Suppl. 1), S312-S313 (2011).
127. Mevorach D, Reiner I, Or R. Single-infusion of donor early apoptotic cells (ApoCell) as prophylaxis of graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation. Blood 120(21), 4176 (2013).
128. Liu Y, Cousin JM, Hughes J et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162(6), 3639-3646 (1999).
129. McCubbrey AL, Sonstein J, Ames TM, Freeman CM, Curtis JL. Glucocorticoids relieve collectin-driven suppression of apoptotic cell uptake in murine alveolar macrophages through downregulation of SIRPa. J. Immunol. 189(1), 112-119 (2012).
130. Lo SZ, Steer JH, Joyce DA. Tumor necrosis factor-a promotes survival in methotrexate-exposed macrophages by an NF-kB-dependent pathway. Arthritis Res. Ther. 13(1), R24 (2011).
131. Lichtenauer M, Mildner M, Hoetzenecker K et al. Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: A preclinical study. Basic Res. Cardiol. 106(6), 1283-1297 (2011).
132. Harel-Adar T, Ben Mordechai T, Amsalem Y, Feinberg MS, Leor J, Cohen S. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc. Natl Acad. Sci. USA 108(5), 1827-1832 (2011).
133. Bournazou I, Pound JD, Duffin R et al. Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J. Clin. Invest. 119(1), 20-32 (2009).
134. Perruche S, Saas P. L14. Immunomodulatory properties of apoptotic cells. Presse. Med. 42(4 Pt 2), 537-543 (2013).
135. Schneemann M, Schoeden G. Macrophage biology and immunology: Man is not a mouse. J. Leukoc. Biol. 81(3), 579; discussion 580 (2007).
136. Fang FC, Nathan CF. Man is not a mouse: Reply. J. Leukoc. Biol. 81(3), 580 (2007).
137. Saas P, Bonnefoy F, Kleinclauss F et al. Towards the use of intravenous apoptotic leukocyte infusion as a cell-based therapy approach? Transfus. Clin. Biol. 15(3), 98-108 (2008).
138. Sokolowski JD, Mandell JW. Phagocytic clearance in neurodegeneration. Am. J. Pathol. 178(4), 1416-1428 (2011).
139. MacDonald JM, Beach MG, Porpiglia E, Sheehan AE, Watts RJ, Freeman MR. The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons. Neuron 50(6), 869-881 (2006).
140. Lu Z, Elliott MR, Chen Y et al. Phagocytic activity of neuronal progenitors regulates adult neurogenesis. Nat. Cell Biol. 13(9), 1076-1083 (2011).
141. Perry VH, Henderson Z, Linden R. Postnatal changes in retinal ganglion cell and optic axon populations in the pigmented rat. J. Comp. Neurol. 219(3), 356-368 (1983).
142. Hall MO, Prieto AL, Obin MS et al. Outer segment phagocytosis by cultured retinal pigment epithelial cells requires Gas6. Exp. Eye Res. 73(4), 509-520 (2001).
143. Nandrot EF, Kim Y, Brodie SE, Huang X, Sheppard D, Finnemann SC. Loss of synchronized retinal phagocytosis and age-related blindness in mice lacking avb5 integrin. J. Exp. Med. 200(12), 1539-1545 (2004).
144. Monks J, Rosner D, Geske FJ et al. Epithelial cells as phagocytes: Apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ. 12(2), 107-114 (2005).
145. Sandahl M, Hunter DM, Strunk KE, Earp HS, Cook RS. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. BMC Dev. Biol. 10, 122 (2010).
146. Golpon HA, Fadok VA, Taraseviciene-Stewart L et al. Life after corpse engulfment: Phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J. 18(14), 1716-1718 (2004).
147. Juncadella IJ, Kadl A, Sharma AK et al. Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature 493(7433), 547-551 (2012).
148. Hall SE, Savill JS, Henson PM, Haslett C. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. J. Immunol. 153(7), 3218-3227 (1994).
149. Gaiffe E, Pretet JL, Launay S et al. Apoptotic HPV positive cancer cells exhibit transforming properties. PLoS ONE 7(5), e36766 (2012).
150. Hess KL, Tudor KS, Johnson JD, Osati-Ashtiani F, Askew DS, Cook-Mills JM. Human and murine high endothelial venule cells phagocytose apoptotic leukocytes. Exp. Cell Res. 236(2), 404-411 (1997).
151. Xie R, Gao C, Li W et al. Phagocytosis by macrophages and endothelial cells inhibits procoagulant and fibrinolytic activity of acute promyelocytic leukemia cells. Blood 119(10), 2325-2334 (2012).
152. Gao C, Xie R, Li W et al. Endothelial cell phagocytosis of senescent neutrophils decreases procoagulant activity. Thromb. Haemost. 109(6), 1079-1090 (2013).
153. Hochreiter-Hufford AE, Lee CS, Kinchen JM et al. Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion. Nature 497(7448), 263-267 (2013).
154. Caruso RA, Fedele F, Finocchiaro G, Arena G, Venuti A. Neutrophil-tumor cell phagocytosis (cannibalism) in human tumors: An update and literature review. Exp. Oncol. 34(3), 306-311 (2012).
155. Xia CQ, Qiu Y, Peng RH, Lo-Dauer J, Clare-Salzler MJ. Infusion of UVB-treated splenic stromal cells induces suppression of b cell antigen-specific T cell responses in NOD mice. J. Autoimmun. 30(4), 283-292 (2008).